University Hospitals of Leicester offers a range of diagnostic, treatment, and support services for patients with many types of cancer.
UHL is part of the East Midlands Cancer Alliance and provides specialist services in areas such as haematological cancers, breast, lung, colorectal, and urological cancers. The Trust combines clinical excellence with research and innovation, working closely with partners such as the University of Leicester and the Leicester Cancer Research Centre to ensure patients benefit from the latest advances in cancer treatment and care.
Cancer care at UHL is delivered by multidisciplinary teams (MDTs) made up of oncologists, surgeons, radiologists, specialist nurses, and allied health professionals, ensuring a coordinated approach tailored to each patient’s individual needs. The Trust is also committed to supporting patients and families throughout their cancer journey, with services ranging from psychological support and palliative care to survivorship and rehabilitation programs.
The 62 Day Pathway
The 62 day pathway is a national guideline for clinicians, other health professionals and administrative staff to ensure individuals are seen and treated within a set time.
Getting referred
The most common way to be referred on to the 62 day pathway is by your GP. Sometimes your dentist or optician may also refer to this is with a ‘Two Week Wait’ or ‘Urgent Suspected Cancer’ appointment. If your GP thinks further investigations are needed, they will refer you to the hospital to see a specialist. Once the hospital receives the referral, the process begins. Following your referral you will either have an appointment at the hospital, or be sent directly for tests such as an MRI scan or a biopsy.
If a cancer is diagnosed (sometimes before diagnosis), your case will be discussed at an Multi-Disciplinary Team (MDT) meeting. This involves many individuals, who will review all of your test results and consider all your personal needs and requirements. From this discussion, your recommended treatment option will be documented. This will be discussed with you at a follow up appointment, by an appropriately trained healthcare professional.
Your treatment start date should be within 62 days of the clock starting (when the GP referral was received by the hospital), and within 31 days of decision to treat (this is when you and the clinician have agreed on your treatment plan).
Unfortunately, it is not always possible to treat within 62 days, for example, there can be appointment delays or further tests may happen if more information is needed. Ongoing work takes place behind the scenes to support timely diagnosis and treatment within the recommended timeframe.
The 31 Day Pathway
The 31 Day Pathway will apply to all patients following a decision to treat. The decision to treat is the point when you and your healthcare professional have agreed what your first treatment will be. This first treatment must start 31 days from this decision. This includes first treatments and any subsequent treatments for cancer.
Treatments types include:
- Surgery
- Chemotherapy, Chemoradiotherapy and Radiotherapy
- Hormone treatments
- Active Monitoring / Watchful Waiting (where no immediate treatment is required)
- Palliative Care / Best Supportive Care (where no active treatments are appropriate)
Personalised Care
Personalised Care is being introduced across the country to support a more systematic and proactive approach to cancer care and rehabilitation to aid recovery. There is more emphasis in empowering people to manage their own care by giving them the appropriate information and support to do so. The aim is to shift from a standard ‘one size fits all’ approach, which is patient-centred and where clinical, psychosocial and practical needs are assessed and managed effectively.
Personalised care is made up of the following elements: